Analytical testing, QC

Ex vivo 3D cell culture tech makes ‘true drug response prediction’ possible: Kiyatec

19-Aug-2019 By Maggie Lynch

Capital Health joins Kiyatec’s clinical trial to validate a patient-specific predictor test to improve response to cancer therapies for glioblastoma and anaplastic astrocytoma.

SGS connecting systems, labs via fully digitalized global network

15-Aug-2019 By Maggie Lynch

SGS’ OneVision initiative is working to standardize record-keeping across the global life sciences industry in an aim to accelerate laboratory testing, development, and eliminate paper-based systems.

People on the Move: Outsourcing-Pharma roundup July ‘19

02-Aug-2019 By Melissa Fassbender

CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.

PPD boosts clinical trials testing with NeoGenomics lab opening in Singapore

01-Aug-2019 By Melissa Fassbender

To further support Asia-Pacific oncology trials, NeoGenomics opens new Singapore-based pharma services laboratory in the same building as PPD Laboratories’ central lab.

Reactor malfunction results in employee death at India-based CRO

11-Jul-2019 By Melissa Fassbender

One worker has died at GVK Bio’s Hyderabad site after a reactor malfunctioned, though the root cause remains unknown, according to the CRO.

People on the Move: Outsourcing-Pharma roundup June ‘19

03-Jul-2019 By Melissa Fassbender

Newly-minted Signant Health named a new CTO, Parexel bolstered its Japan presence, and BioAgilytix’s CEO was appointed to the board of FSD Pharma – a company developing products based on cannabinoids – among other people on the move in June.

Concept Life Sciences providing ‘fully integrated offering’ in the early development space

24-Jun-2019 By Melissa Fassbender

The drug discovery, development, and analytical service provider has opened a new facility in Sandwich, UK to support the development and manufacturing of APIs – a market expected to top $270bn by 2026.

FDA to ‘institutionalize’ compounding regulation to ‘protect consumers’

19-Jun-2019 By Nick Taylor

The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching patients.

Aptar scoops up two pharma services firms in $50m deal

11-Jun-2019 By Melissa Fassbender

Aptar Group acquires two pharmaceutical services companies, Nanopharm and Gateway Analytical, to boost its analytical, testing, and development capabilities.

GSK spinoffs join forces as single CRO providing immunology lab services

10-Jun-2019 By Melissa Fassbender

Neomed-Labs/Pacific Biomarkers last week announced its acquisition of PairImmune in a bid to expand its immunology offerings.

Covance to invest $5.7m in new equipment, hire 203 at Indianapolis site

10-Jun-2019 By Melissa Fassbender

Covance seeks an Economic Revitalization Area designation at its Indianapolis, IN-based site, at which the company looks to expand its sample storage capacity and add space “dedicated to innovation" as part of an $11.8m construction project.

ElevateBio secures $150m to move cell and gene therapy companies forward amid ‘overwhelming’ CMO demand

06-Jun-2019 By Melissa Fassbender

ElevateBio’s BaseCamp facility will provide “bench-to-bedside” services to its portfolio and partner companies – as the demand for cell and gene therapy CMOs “far outweighs the capacity,” says CEO.

Scientist.com teams up with VC firm to create marketplace for biotech

03-Jun-2019 By Melissa Fassbender

The online marketplace for outsourced R&D services Scientist.com partners with 5AM Ventures to help researchers save time and money – as the industry is "caught between a rock and a hard place," says CEO.

Accenture launches AI tool to improve connectivity between researchers

30-May-2019 By Vassia Barba

Accenture’s technology platform, Intient, will provide access to clinical data and links companies working on drug delivery.

BASi acquires Smithers Avanza’s tox services business unit

06-May-2019 By Melissa Fassbender

Bioanalytical Systems acquires Smithers Avanza Toxicology Services business unit in response to a strong demand for its toxicology and drug disposition services.